Vésale Bioscience Rebrands as Inteliphage, Signaling Shift Toward Clinical Application of Phage Therapy July 23, 2025 Belgian biotech company Vésale Bioscience has officially rebranded as Inteliphage, marking a strategic evolution in its mission and scope. The company, known for its…
Phage Therapy Breaks New Ground in Combating Drug-Resistant Mycobacterial Infections September 17, 2023 In the ongoing battle against drug-resistant Mycobacterial infections, a ray of hope has emerged from the world of bacteriophages. The study, titled “Phage Therapy…
Bacteriophages Successfully Treat Antibiotic-Resistant Lung Infections June 27, 2023 A team of researchers from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) has achieved a significant breakthrough by using bacteriophages…
Phage mediated therapy for cancer January 22, 2022 Bacteriophages are viruses that have high specificity for their hosts. Given the fact that their target host is bacteria, it makes them an attractive…
